Komodo Health has announced significant updates to its MapEnhanceTM platform, enhancing the depth and breadth of insights into social determinants of health (SDOH) while introducing new specialty data partners, GeneDx and COTA Healthcare. These updates empower companies to leverage Komodo’s integrated analytics solution, providing comprehensive views of clinical encounters and a deeper understanding of how social and environmental factors influence patient outcomes. The integration of GeneDx's genetic dataset with Komodo's Healthcare Map advances precision medicine, while partnerships with COTA Healthcare enrich cancer care insights, supporting more effective treatments.
MapEnhance, available exclusively through Komodo’s AI-powered platform, offers a library of specialty datasets, including genomics, electronic health records, and demographic information, facilitating longitudinal research across various disease categories. Through partnerships with leading healthcare data providers, Komodo broadens its SDOH intelligence and facilitates impactful decision-making in commercial strategies and medical breakthroughs. The platform's expansion also includes exclusive Komodo-built data assets, curated by data scientists and AI experts, reinforcing its role as a key player in generating real-world evidence to address global health challenges.
